Uterine Myoma. Leiomyoma of uterus
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Age range 40-25 years Intra molar myomas are less than 50% prominent in the uterine cavity. Patients with leiomyoma who have been treated for myomas have not used hormonal drugs, including GNRH agonists, progesterone, and so on.
Exclusion criteria
Exclusion criteria: Patients with uterine obstruction, AUB, PCO and , taking hormonal drugs and Patients with hormonal disorders Patients with Polycystic ovary syndrome Patients with abnormal uterine bleeding Patients with metabolic disorders Patients taking hormonal drugs. Patients with uterine polyps
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Size of myoma. Timepoint: Three months after taking the drug. Method of measurement: sonography.;Number of uterine fibroids. Timepoint: Three months after taking the drug. Method of measurement: sonography. | — |
Secondary
| Measure | Time frame |
|---|---|
| PGE2 levels in uterine fluid. Timepoint: Three months after taking the drug. Method of measurement: Measurement in the laboratory.;The amount of aromatase and PGES genes. Timepoint: Three months after taking the drug. Method of measurement: Measurement in the laboratory. | — |
Countries
Iran (Islamic Republic of)
Contacts
Tabriz University of Medical Sciences